B

엠아이텍

179290KOSDAQ의료용 기기 제조업

64.5 / 100

Reference Date: 2026-04-13

Financial Score34.0 / 40
News Sentiment12.5 / 25
Momentum8.0 / 20
Disclosure10.0 / 15
AI Analysis: PER is significantly undervalued vs. peers and ROE significantly exceeds the industry average is also solid. Slightly down 2.0% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

MITEC is a company that pioneered the development of non-vascular stents in South Korea, expanding its product portfolio and exporting to overseas markets. It obtained CE MDR certification in 2023 to enter the European market and is expanding its presence in the endoscopy sector by distributing Fujifilm endoscopy equipment.

Number of Employees

179people

Average Salary

52.7M KRW

Score Calculation Basis

Detailed Financial Score

PER
10.66Industry Average 26.528.0Point

Half of industry avg (excellent)

PBR
1.72Industry Average 1.702.5Point

Higher than industry avg (caution)

ROE
17.32Industry Average 8.007.0Point

2.2x industry avg (excellent)

Debt Ratio
5.27Industry Average 10.956.5Point

Half of industry avg (excellent)

Trend 2023~202510.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲20.4% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲21.3% (2-year basis)

ROE Trend
4.0 / 4

Avg ROE 16.7% (improving, 3yr)

Detailed News Sentiment

3 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position3.0Point

52w lower range (25%)

Current 6,700Won52-week high 8,45052-week low 6,090
1-month return2.0Point

1m -2.05% (slight drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

5 totalPositive 0Neutral 5Negative 0
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-02
  • Neutral주식등의대량보유상황보고서(일반)2026-04-02
  • Neutral정기주주총회결과2026-03-26
  • Neutral감사보고서제출2026-03-18
  • Neutral사업보고서 (2025.12)2026-03-18